Tab Gida Sanayi ve Ticaret AS
IST:TABGD.E
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
149
249
|
| Price Target |
|
We'll email you a reminder when the closing price reaches TRY.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
TABGD.E Price Targets Summary
Tab Gida Sanayi ve Ticaret AS
According to Wall Street analysts, the average 1-year price target for TABGD.E is 308.63 TRY with a low forecast of 247.11 TRY and a high forecast of 357.08 TRY.
Operating Income
Forecast
Operating Income Estimate
Tab Gida Sanayi ve Ticaret AS
For the last 2 years the compound annual growth rate for Tab Gida Sanayi ve Ticaret AS's operating income is 229%. The projected CAGR for the next 4 years is 47%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TABGD.E's stock price target?
Price Target
308.63
TRY
According to Wall Street analysts, the average 1-year price target for TABGD.E is 308.63 TRY with a low forecast of 247.11 TRY and a high forecast of 357.08 TRY.
What is Tab Gida Sanayi ve Ticaret AS's Revenue forecast?
Projected CAGR
33%
For the last 2 years the compound annual growth rate for Tab Gida Sanayi ve Ticaret AS's revenue is 39%. The projected CAGR for the next 4 years is 33%.
What is Tab Gida Sanayi ve Ticaret AS's Operating Income forecast?
Projected CAGR
47%
For the last 2 years the compound annual growth rate for Tab Gida Sanayi ve Ticaret AS's operating income is 229%. The projected CAGR for the next 4 years is 47%.
What is Tab Gida Sanayi ve Ticaret AS's Net Income forecast?
Projected CAGR
83%
For the last 2 years the compound annual growth rate for Tab Gida Sanayi ve Ticaret AS's net income is 2%. The projected CAGR for the next 2 years is 83%.